يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Laura Hogenboom"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3

    المساهمون: Neurology, VU University medical center, Epidemiology and Data Science, APH - Methodology, Amsterdam Neuroscience - Neuroinfection & -inflammation, AII - Inflammatory diseases, Landsteiner Laboratory

    المصدر: Journal of Neurology, Neurosurgery and Psychiatry, 94(6):jnnp-2022-330793, 487-493. BMJ Publishing Group
    Toorop, A A, Hogenboom, L, Bloem, K, Kocyigit, M, Commandeur, N W M, Wijnants, A, Lissenberg-Witte, B I, Strijbis, E M M, Uitdehaag, B M J, Rispens, T, Killestein, J & van Kempen, Z L E 2023, ' Ocrelizumab concentration and antidrug antibodies are associated with B-cell count in multiple sclerosis ', Journal of Neurology, Neurosurgery and Psychiatry, vol. 94, no. 6, jnnp-2022-330793, pp. 487-493 . https://doi.org/10.1136/jnnp-2022-330793Test
    Journal of Neurology, Neurosurgery and Psychiatry. BMJ Publishing Group

  4. 4

    المساهمون: Neurology, Amsterdam Neuroscience - Neuroinfection & -inflammation, AII - Inflammatory diseases

    المصدر: van Kempen, Z L E, Hogenboom, L & Killestein, J 2022, ' Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing : NO ', Multiple Sclerosis Journal, vol. 28, no. 5, pp. 693-695 . https://doi.org/10.1177/13524585211064441Test
    Multiple Sclerosis Journal, 28(5), 693-695. SAGE Publications Ltd